New drugs for the treatment of metastatic colorectal cancer

Colorectal cancer (CRC) represents one of the most frequent malignancies in terms of incidence and mortality, thus representing the third leading cause of cancer death worldwide. In the last decade, few drugs have enriched the treatment landscape of metastatic CRC and have significantly affected pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherri, Sara, Libertini, Michela, Zaniboni, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603451/
https://www.ncbi.nlm.nih.gov/pubmed/34853636
http://dx.doi.org/10.4251/wjgo.v13.i11.1551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603451/
https://www.ncbi.nlm.nih.gov/pubmed/34853636
http://dx.doi.org/10.4251/wjgo.v13.i11.1551

Ejemplares similares